variations, type A is the most common type found followed by type B and then the extremely rare type AB. 2 The A and B red blood cell (RBC) antigens represent sialic N-glycolyl-and N-acetyl-neuraminic acids, respectively. The AB erythrocytes express both N-glycolyl-and N-acetyl-neuraminic acids. 3 Several genetic variants (mutations) have been identified in the Cytidine Monophosphate-N-Acetylneuramic acide hydrolase (CMAH) gene associated with type A, B, and AB, but the precise functional effects of these variants have not been determined, and genotyping assays have not been completely accurate until recently. [3] [4] [5] In addition, Mik has been proposed as an additional feline blood group system with potentially naturally occurring alloantibodies in some
Mik-negative cats. 6 Rarely other blood types are suspected based upon crossmatch (XM) incompatibilities pre-and post-transfusion and/or acute hemolytic transfusion reactions despite A-B matching.
5,7
A-B typing of recipients and donors (as well as mates before breeding) is recommended to assure A-B compatibility. 5, [8] [9] [10] A-B matched transfusions are required to be effective, and ignoring A-B blood typing can result in serious acute hemolytic transfusion reactions. 5, 10 A-B mismatches can also induce neonatal isoerythrolysis.
Although originally feline anti-A and anti-B antisera and lectins (Triticum vulgaris as anti-B) have been used for typing, 1 typing kits utilizing monoclonal anti-A and anti-B alloantibodies have been used in clinical practice for a couple of decades. [11] [12] [13] Although canine blood as xenotransfusion is occasionally used, it leads to rapid destruction of canine
RBCs in first few days (acute hemolytic transfusion reaction) and is fatal upon a second transfusion; therefore, this practice is not recommended. [14] [15] [16] For decades, blood typing in cats has been recommended before the first transfusion and XM has been recommended before a second transfusion when given after more than 4 days. 10 There is some evidence for the presence of other naturally occurring alloantibodies outside the AB blood group system, like anti-Mik, but their importance at the time of a first transfusion has not been clearly defined clinically and experimentally. 5, 17, 18 Some also perform crossmatching in addition to AB typing before a first transfusion due to the potential presence of naturally occurring alloantibodies outside of the AB system, such as anti-Mik. 5, 7, 18, 19 However, crossmatching cats is technically restricted by the difficulty to obtain blood samples from recipient and donor cat before transfusion, limited availability of standardized crossmatching protocols and expertise to perform elaborate XM assays, and lack of any in-clinic kits for crossmatching cats.
5,10
The purpose of this prospective study was to detect naturally occurring alloantibodies by a new in-clinic feline antiglobulinenhanced gel tube XM test in cats compared to a laboratory gel column card method to establish XM recommendations in cats not previously transfused. The second aim of the study was to assess the correlation between the two tests. 
| MATERIALS AND METHODS

| Animals and blood sample collection
| Laboratory methods
Aliquots of EDTA-anticoagulated whole-blood samples were used directly for AB blood typing by immunochromatographic strip kit (CHROM Method, Lab Test A + B; Alvedia, Limonest, France), and the remaining blood was centrifuged at 1000g for 10 minutes to prepare packed red blood cells (pRBCs) as well as plasma from each cat for AB typing with flow cytometry and XM testing using 2 different techniques. The pRBCs were stored at 4 C, and the remaining plasma was frozen at −20 C for XM testing. 
| Feline AB typing
| Gel column XM without antiglobulin
Crossmatch tests were performed and interpreted according to the manufacturer's instructions (Bio-Rad, DiaMed GmbH, Cressier, Switzerland) and as previously described. 11, 21 In a 3-mL polystyrene test tube, 50 μL of 1% donor pRBCs in low ionic strength solution (LISS; Bio-Rad, DiaMed GmbH) were added to 25 μL of recipient plasma, briefly mixed, and incubated at 22 C for 10 minutes. The RBC suspension was placed on top of the GC, filled with neutral gel (no antiglobulin). The GC cards were centrifuged (ID Centrifuge 6S;
Bio-Rad DiaMed GmbH) at 80g for 10 minutes, and the location of the migrated RBCs was recorded. In the absence of agglutination, the RBCs passed through the gel to the bottom, which was scored as "compatible," whereas agglutination on the top of or within the gel was considered "incompatible." Auto-controls (using RBCs and plasma from same cat) and positive controls (using murine monoclonal anti-A and anti-B antibodies) were included for all XM tests performed.
| Antiglobulin-enhanced gel column XM kit
An antiglobulin-enhanced gel technique routinely used in human medicine [22] [23] [24] was adapted as a novel in-clinic XM kit for cats 6 
| Statistical analysis
Descriptive data are presented as median, range, and percentage. The XM test results were compared using Wilcoxon's test and Spearman rho's test. The statistical analyses were performed using a commercially available statistical program (GraphPad Prism 7; GraphPad Software, Inc., La Jolla, California), and a P ≤ .05 was considered significant.
3 | RESULTS
| AB typing results
Forty-nine domestic shorthair cats from Lyon (France) were included in the study over a 6-month period. There were 28 males and 21 females (Supporting Information Table S1 ). Their median age was 7 months (range, 6-51 months), and their median PCV was 46% (range, 38%-50%). According to both flow cytometry and immunochromatographic strip kit methods for AB typing, 34 (69%) cats had A RBCs again by both methods suggesting a lack of anti-A alloantibodies ( Figure 3 ). This cat was followed 6 months later after the study completion, and blood type B was again confirmed using both flow cytometry and immunochromatography. Further GC and AGC XMs were both compatible between this cat's plasma and pRBCs from 7 type A cats, different from those previously included in this study.
Furthermore, the RBCs from 1 AB cat (CAT49) reacted with plasma from 7 B cats but with none of the 10 tested plasma samples from A cats. This cat's typing results showed a stronger type A than type B band and MFI for the A antigen (Supporting Information Table S1 ).
There were discordant results between methods with samples involving type A, B, and AB cats, which will be further detailed below.
These additional incompatibilities were only detected with AGC XM method in 15 of 446 pairings, whereas the GC XM test results indicated compatibility ( There are several typing kits available for the feline AB blood system in clinical settings including agglutination card, immunochromatographic strip, and cartridge techniques. [11] [12] [13] Recent reports compared them with each other and indicated that immunochromatographic strip method showed better performance than agglutination card. 11, 12 Furthermore, flow cytometry is a blood typing method used in research laboratories available to settle discordant typing results by other techniques. 1 This study compared immunochromatographic strip method to the laboratory flow cytometry technique, both utilizing the same monoclonal antibodies for feline AB typing, giving completely concordant results for all type A (69%), B (27%), and AB (4%) blood samples.
Discordant typing results have been reported previously with various methods and mostly related to the AB blood type. It has been recommended to confirm any AB blood type result by another method and perform also back typing, that is, checking for the presence of alloantibodies. Moreover, molecular genetic approaches could be applied to further define the A, B, and AB blood type, those have been described for type AB for the Ragdoll breed and recently for A-B blood group system in domestic cats. 3, 4 Similarly, it is also recommended to confirm the type B blood with a second method and back typing or XM in clinical practice. A recipient cats and acute hemolytic transfusion reactions outside the AB system were reported. 6 Furthermore, naturally occurring alloantibodies against the Mik antigen were found, whereas a recent study in the United Kingdom about transfusion-naive cats revealed no major XM incompatibilities on 112 XMs performed. 7 In addition, another recent study does not support the use of the major XM test to increase efficacy of, and to decrease adverse events associated with RBC transfusion in AB blood typed transfusion-naive cats. 26 Those differences could be explained by the lack of XM test sensitivity and method standardization; the XM methods used in those studies did not use antiglobulin-enhanced assays. Also cats with a different health status and coming from other countries may influence these compatibility test results. In 2014, a retrospective study showed that administering XM compatible RBCs to cats as compared to noncrossmatched led to a greater increase in the post-transfusion PCV, but the groups were small and the non-crossmatched group was considered to be too sick to wait for a XM and thus were at higher risk of dying and were not comparable to the crossmatch group. 18 The establishment of a more feasible and reliable XM test, as described in our study, appears of growing importance to prevent acute hemolytic transfusion reactions due to blood type incompatibilities in either naive and previously transfused cats as per XM test results. The clinical importance of the detected alloantibodies outside the AB (and Mik-) system still needs to be determined.
In human transfusion medicine, alloimmunization is a common posttransfusion sequelae and has been also described in dogs 21, 28 and recently for cats. 5, 17 Recently, development of alloantibodies against erythrocyte antigens outside the AB system has been observed in 25% of an anemic cat population after the first transfusion event. 17 It has, therefore, been recommended to introduce crossmatching into routine pretransfusion testing protocols and encouraged the development of in-clinic feline XM tests. 6, 17 Moreover, as in human transfusion medicine, clerical errors may occur and result in life-threatening acute hemolytic transfusion reactions. 5, 8, 14 Thus, a second level of compatibility testing besides A-B matching can be further assuring.
In veterinary medicine, several XM tests are available. The first methods reported in cats were slide and tube methods, but problems with these techniques included labor-intensiveness, required technical expertise, rouleaux confused for agglutination, lack of standardization of methods, weakly false-positive and false-negative results particularly in anemic cats, and interobserver variation in interpretation. The standard laboratory XM technique (tube) was considered the gold standard method but requires expertise, is time consuming, and its reliability has been shown to be very operator dependent. 29 To address these problems in human medicine, the GC method was developed in the late 1980s and is easy to use, requires small blood samples, is more sensitive and easier to grade, thereby helping standardization. This GC technique has also been used in companion animals (dogs, cats, and horses) and shown to be effective (without using antiglobulins). 5, 10, 14 Moreover, human studies showed that using XM test with species specific antiglobulin improves the sensitivity of the test for detecting [22] [23] [24] False-positive reactivity has been described with gel methods and has been partially explained by the low-ionic wash solution used commercially in acid-elution kits. 24 In this study, we used the same LISS in both GC and AGC. The AGC test showed concordant results with GC test but AGC test detected more A-B and non-A-B system incompatibilities.
Moreover, all auto-controls were negative, which do not support the existence of false-positive results. Furthermore, performing blood transfusion between XM-incompatible cats would represent the only way to look for false-positive results, which was not performed (unethical).
These results confirm the presence of naturally occurring alloantibodies not only against type A or B RBCs but also yet to be defined antigens.
Although serious transfusion reactions have been reported due to A-B incompatibilities, 8 the clinical importance of these other alloantibodies was not determined. These findings yet confirm the importance of using antiglobulin-enhanced XM technique to increase the sensitivity in detecting potentially important alloantibodies.
Limitations of our study are the small cohort on animals despite the large number of XM tests, the lack of a definitive reference XM method, and the fact that all laboratory tests were performed by two well-trained medical technologists. Although they did not know of the immunochromatographic strip typing results when performing the flow cytometric evaluations, they selected the pairings based upon the typing results and were aware of the blood types in each pairing.
In conclusion, feline AB typing with the immunochromatographic strip kit is as accurate as the laboratory flow cytometry. The 2 XM test results showed good agreement, but using an antiglobulin-enhanced XM kit revealed additional incompatibilities outside the AB blood group system. The associated RBCs antigens and clinical importance of these other naturally occurring alloantibodies remain to be determined. Based upon this prospective study as well as prior publications on naturally occurring alloantibodies in type B and to a lesser degree in type A cats as well as potentially naturally occurring anti-Mik and other alloantibodies, it is recommended to not only type cats for AB compatibility but also to XM cats before a first transfusion.
